Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 79 Myelodysplastic Syndromes 42 Leukemia 23 Leukemia, Myelomonocytic, Chronic 20 Congenital Abnormalities 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Recurrence 7 Neoplasms 7 Myeloproliferative Disorders 7 Blast Crisis 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Myeloid, Accelerated Phase 5 Carcinoma, Non-Small-Cell Lung 5 Thrombocythemia, Essential 4 Primary Myelofibrosis 4 Polycythemia Vera 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lung Neoplasms 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Burkitt Lymphoma 3 Anemia, Refractory, with Excess of Blasts 3 Anemia, Refractory 3 Small Cell Lung Carcinoma 2 Neuroblastoma 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2

Interventions

Doxorubicin 80 Ifosfamide 54 Radiotherapy 43 Filgrastim 41 Gemcitabine 38 Cyclophosphamide 34 Etoposide 26 Vincristine 24 Cisplatin 24 Docetaxel 23 pazopanib 21 Trabectedin 19 Carboplatin 17 pembrolizumab 15 Peripheral Blood Stem Cell Transplantation 14 eribulin 12 Mesna 12 Melphalan 12 Sorafenib 11 Sirolimus 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Bevacizumab 11 Topotecan 10 Paclitaxel 10 Imatinib Mesylate 10 Chemotherapy, Adjuvant 10 pegfilgrastim 9 Temozolomide 9 Surgical Procedures, Operative 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × Decitabine × Clear all

NCT02959164 2023-07-28

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

University of Iowa

Phase 1 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡